Alteration of myo-inositol monophosphatase in Alzheimer's disease brains

Neuroscience Letters

Volumn 245, Issue 3, 1998, Pages 159-162

  Shimohama, Shun ^a   Tanino, Hiroko ^b   Sumida, Yasuo ^b   Tsuda, Junji ^b   Fujimoto, Sadaki ^b  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Brain; Human; Myo inositol; Myo inositol monophosphatase; Phospholipid metabolism

Indexed keywords

INOSITOL 1 PHOSPHATASE; PHOSPHATASE;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; GEL FILTRATION CHROMATOGRAPHY; NONHUMAN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; RAT; SECOND MESSENGER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; BRAIN; HUMANS; PHOSPHOLIPIDS; PHOSPHORIC MONOESTER HYDROLASES; RATS; RATS, WISTAR;

EID: 0032502633     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00209-2     Document Type: Article

References (18)

1. Berridge M.J., Downes C.P., Hanley M.R. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem. J. 206:1982;587-595.
2. Berridge M.J. Inositol trisphosphate and diacylglycerol as second messengers. Biochem. J. 220:1984;345-360.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
4. Chen P.S., Toribara T.Y., Warner H. Microdetermination of phosphorus. Anal. Chem. 28:1956;1756-1758.
5. Farooqui A.A., Wells K., Horrocks A. Breakdown of membrane phospholipids in Alzheimer's disease. Involvement of excitatory amino acid receptors. Mol. Chem. Neuropath. 25:1995;155-173.
6. Gee N.S., Ragan C.I., Watling K.J., Aspley S., Jackson R.G., Reid G.G., Gani D., Shute J.K. The purification and properties of myo-inositol monophosphatase from bovine brain. Biochem. J. 249:1988;883-889.
7. Hallcher L.M., Sherman W.R. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J. Biol. Chem. 255:1980;10896-10901.
8. Kanfer J.N., Singh I.N., Pettegrew J.W., McCartney D.G., Sorrentino G. Phospholipid metabolism in Alzheimer's disease and in a human cholinergic cell. J. Lipid. Mediators Cell Signalling. 14:1996;361-363.
9. Klunk W.E., Xu C., Panchalingam K., McClure R.J., Pettegrew J.W. Quantitative 1H and 31P MRS of PCA extracts of postmortem Alzheimer's disease brain. Neurobiol. Aging. 17:1996;349-357.
10. Majerus P.W. Inositol phosphate biochemistry. Annu. Rev. Biochem. 61:1992;225-250.
11. Miller B.L., Moats R.A., Shonk T., Ernst T., Woolley S., Ross B.D. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology. 187:1993;433-437.
12. Nitsch R.M., Blusztajn J.K., Pittas A.G., Slack B., Growdon J.H., Wurtman R.J. Evidence for a membrane defect in Alzheimer's disease brain. Proc. Natl. Acad. Sci. USA. 89:1992;1671-1675.
13. Shimohama S., Fujimoto S., Chachin M., Taniguchi T., Perry G., Whitehouse P.J., Kimura J. Alteration of low molecular weight acid phosphatase protein level in Alzheimer's disease. Brain Res. 699:1995;125-129.
14. Shonk T.K., Ross B.D. Role of increased cerebral myo-inositol in the dementia of Down syndrome. Magn. Reson. Med. 33:1995;858-861.
15. Spector R. myo-Inositol transport through the blood-brain barrier. Neurochem. Res. 13:1988;785-787.
16. Stokes C.E., Gillon K.R.W., Hawthorne J.N. Free and total lipid myo-inositol concentrations decrease with age in human brain. Biochim. Biophys. Acta. 753:1983;136-138.
17. Stokes C.E., Hawthorne J.N. Reduced phosphoinositide concentrations in anterior temporal cortex of Alzheimer disease brains. J. Neurochem. 48:1987;1018-1021.
18. Wells K., Farooqui A.A., Liss L., Horrocks L. Neural membrane phospholipids in Alzheimer's disease. Neurochem. Res. 20:1995;1329-1333.